Literature DB >> 19845722

Should dermatologists prescribe hormonal contraceptives for acne?

Julie C Harper1.   

Abstract

ABSTRACT One of the primary factors contributing to the development of acne vulgaris is excess sebum. Sebaceous glands and sebum excretion are regulated, at least in part, by androgen hormones. Acne treatments that block this androgen effect include spironolactone and combination oral contraceptives (COC). Three COC are now FDA approved to treat moderate acne. Dermatologists must become experts at prescribing these hormonal contraceptives. Likewise, it is vital to be aware of contraindications to hormonal contraceptive therapy. Proper patient selection relies on an appropriate medical history and an assessment of blood pressure. A pelvic exam and/or Papanicolaou smear are not required prior to initiating therapy with a COC. It is important to counsel patients about potential adverse effects of COC pills and to establish appropriate expectations concerning acne improvement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845722     DOI: 10.1111/j.1529-8019.2009.01261.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  2 in total

Review 1.  Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream.

Authors:  Carol Sanchez; Jonette Keri
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-15

2.  Profiling and hormonal therapy for acne in women.

Authors:  Sangita Ghosh; Soumik Chaudhuri; Vijay Kumar Jain; Kamal Aggarwal
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.